OBJECTIVE: Owing to its unique configuration of two adjustable plate detectors positron emission mammography, or PEM, could theoretically also function as a high-resolution positron emission scanner for the extremities or neck. PEM quantitates its activity via a "PEM uptake value," or PUV, and although its relationship to the standardized uptake value, or SUV, has been demonstrated in the breasts, to our knowledge there are no studies validating PUV in other sites such as the extremities. MATERIALS AND METHODS: This was a retrospective chart review of two separate protocols of a total of 15 patients. The patients all had hypermetabolic lesions in the extremities or neck on imaging with PET/CT and were sent after their PET/CT to PEM for further imaging. Owing to the sequential nature of these examinations no additional radiotracer was administered. RESULTS: Spearman's rank order correlation was calculated between the PUVmax obtained from PEM images, and the SUVmax for all. Spearman's rank order correlation for all sites was 0.42, which is not significantly different from 0 (p = 0.13). When neck lesions were excluded from the group, there was a strong and statistically significant correlation between PUVmax and SUVmax, with Spearman's rank correlation of 0.73, and significantly different from 0 (p = 0.0068). DISCUSSION: The correlation of PUV and SUV in the extremities indicates the potential use of PEM as a semiquantitative, high-resolution positron emission scanner and warrants further investigation, especially in the realms of disease processes that often present in the extremities, such as melanoma, osteomyelitis, and arthritis, as well as playing a role in the imaging of patients with metallic hardware post-limb salvage surgery.
OBJECTIVE: Owing to its unique configuration of two adjustable plate detectors positron emission mammography, or PEM, could theoretically also function as a high-resolution positron emission scanner for the extremities or neck. PEM quantitates its activity via a "PEM uptake value," or PUV, and although its relationship to the standardized uptake value, or SUV, has been demonstrated in the breasts, to our knowledge there are no studies validating PUV in other sites such as the extremities. MATERIALS AND METHODS: This was a retrospective chart review of two separate protocols of a total of 15 patients. The patients all had hypermetabolic lesions in the extremities or neck on imaging with PET/CT and were sent after their PET/CT to PEM for further imaging. Owing to the sequential nature of these examinations no additional radiotracer was administered. RESULTS: Spearman's rank order correlation was calculated between the PUVmax obtained from PEM images, and the SUVmax for all. Spearman's rank order correlation for all sites was 0.42, which is not significantly different from 0 (p = 0.13). When neck lesions were excluded from the group, there was a strong and statistically significant correlation between PUVmax and SUVmax, with Spearman's rank correlation of 0.73, and significantly different from 0 (p = 0.0068). DISCUSSION: The correlation of PUV and SUV in the extremities indicates the potential use of PEM as a semiquantitative, high-resolution positron emission scanner and warrants further investigation, especially in the realms of disease processes that often present in the extremities, such as melanoma, osteomyelitis, and arthritis, as well as playing a role in the imaging of patients with metallic hardware post-limb salvage surgery.
Authors: Jan Fritz; Elliot K Fishman; Frank Corl; John A Carrino; Kristy L Weber; Laura M Fayad Journal: AJR Am J Roentgenol Date: 2012-03 Impact factor: 3.959
Authors: Nicholas A Shkumat; Adam Springer; Christopher M Walker; Eric M Rohren; Wei T Yang; Beatriz E Adrada; Elsa Arribas; Selin Carkaci; Hubert H Chuang; Lumarie Santiago; Osama R Mawlawi Journal: Med Phys Date: 2011-09 Impact factor: 4.071
Authors: Vasileios Kalles; George C Zografos; Xeni Provatopoulou; Dimitra Koulocheri; Antonia Gounaris Journal: Breast Cancer Date: 2012-12-13 Impact factor: 4.239
Authors: N Avril; C A Rosé; M Schelling; J Dose; W Kuhn; S Bense; W Weber; S Ziegler; H Graeff; M Schwaiger Journal: J Clin Oncol Date: 2000-10-15 Impact factor: 44.544
Authors: T Beyer; U Pietrzyk; C Knoess; S Vollmar; K Wienhard; L Kracht; A Bockisch; S Maderwald; H Kühl; M Fitzek Journal: Nuklearmedizin Date: 2008 Impact factor: 1.379
Authors: Anne Roivainen; Riitta Parkkola; Timo Yli-Kerttula; Pertti Lehikoinen; Tapio Viljanen; Timo Möttönen; Pirjo Nuutila; Heikki Minn Journal: Arthritis Rheum Date: 2003-11
Authors: Brenda F Kurland; Vijayakrishna K Gadi; Jennifer M Specht; Kimberly H Allison; Robert B Livingston; Eve T Rodler; Lanell M Peterson; Erin K Schubert; Xiaoyu Chai; David A Mankoff; Hannah M Linden Journal: EJNMMI Res Date: 2012-06-25 Impact factor: 3.138